These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 23345372)

  • 1. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation.
    Atwell TD; Schmit GD; Boorjian SA; Mandrekar J; Kurup AN; Weisbrod AJ; Chow GK; Leibovich BC; Callstrom MR; Patterson DE; Lohse CM; Thompson RH
    AJR Am J Roentgenol; 2013 Feb; 200(2):461-6. PubMed ID: 23345372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous cryoablation of anterior renal masses: technique, efficacy, and safety.
    Schmit GD; Atwell TD; Leibovich BC; Callstrom MR; Kurup AN; Woodrum DA; Charboneau JW
    AJR Am J Roentgenol; 2010 Dec; 195(6):1418-22. PubMed ID: 21098204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
    Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
    Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses.
    Hinshaw JL; Shadid AM; Nakada SY; Hedican SP; Winter TC; Lee FT
    AJR Am J Roentgenol; 2008 Oct; 191(4):1159-68. PubMed ID: 18806159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation.
    Hegarty NJ; Gill IS; Desai MM; Remer EM; O'Malley CM; Kaouk JH
    Urology; 2006 Jul; 68(1 Suppl):7-13. PubMed ID: 16857454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes.
    Moynagh MR; Schmit GD; Thompson RH; Boorjian SA; Woodrum DA; Curry TB; Atwell TD
    J Vasc Interv Radiol; 2015 Jun; 26(6):800-6. PubMed ID: 25840835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation of renal tumors in the solitary kidney.
    Krambeck AE; Farrell MA; Callstrom MR; Atwell TD; Charboneau JW; Chow GK; Dimarco DS; Patterson DE
    Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
    Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures.
    Atwell TD; Carter RE; Schmit GD; Carr CM; Boorjian SA; Curry TB; Thompson RH; Kurup AN; Weisbrod AJ; Chow GK; Leibovich BC; Callstrom MR; Patterson DE
    J Vasc Interv Radiol; 2012 Jan; 23(1):48-54. PubMed ID: 22037491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
    Forauer AR; Dewey BJ; Seigne JD
    Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients.
    Schmit GD; Atwell TD; Callstrom MR; Farrell MA; Leibovich BC; Patterson DE; Chow GK; Blute ML; Charboneau JW
    J Endourol; 2010 Aug; 24(8):1255-62. PubMed ID: 20380510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliation of painful metastatic disease involving bone with imaging-guided treatment: comparison of patients' immediate response to radiofrequency ablation and cryoablation.
    Thacker PG; Callstrom MR; Curry TB; Mandrekar JN; Atwell TD; Goetz MP; Rubin J
    AJR Am J Roentgenol; 2011 Aug; 197(2):510-5. PubMed ID: 21785102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
    Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
    Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
    Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
    J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
    Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous renal cryoablation: local control at mean 26 months of followup.
    Atwell TD; Callstrom MR; Farrell MA; Schmit GD; Woodrum DA; Leibovich BC; Chow GK; Patterson DE; Blute ML; Charboneau JW
    J Urol; 2010 Oct; 184(4):1291-5. PubMed ID: 20719341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study.
    Nakasone Y; Kawanaka K; Ikeda O; Tamura Y; Yamashita Y
    Acta Radiol; 2012 May; 53(4):410-4. PubMed ID: 22393159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.